Brief: Rafael Holdings And Cyclo Therapeutics Enter Into A Definitive Merger Agreement
22/08/2024 12:35
Aug 22 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* RAFAEL HOLDINGS AND CYCLO THERAPEUTICS ENTER INTO A
DEFINITIVE
MERGER AGREEMENT
* RAFAEL HOLDINGS INC - TO ISSUE CLASS B STOCK TO CYCLO
SHAREHOLDERS
* RAFAEL HOLDINGS: INTENDS TO FUND TRANSPORTNPC CLINICAL
TRIAL TO
48-WEEK INTERIM ANALYSIS
* RAFAEL HOLDINGS: PROPOSED DEAL FOR CYCLO THERAPEUTICS
SHARES AT
$0.95 PER SHARE
Source text for Eikon: ID:nBw3XdH8Ga
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rafael Holdings
See all newsBrief: Rafael Holdings Announces Topline Results From The Pivotal Phase 3 Transportnpc™ Study Of Trappsol® Cyclo™ In Niemann-Pick Disease Type C (Npc)
Israel expects new air defence orders from Europe due to Russia concerns
Biotech firm Rafael's Q3 net loss narrows; set to submit NDA for Trappsol Cyclo in H2
Rafael Holdings Q2 net loss widens on consolidation of Cyclo Therapeutic's costs
Brief: Rafael Holdings Q2 Net Income USD -6.327 Million